Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Biotransformation of an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist in Sprague-Dawley Rats and the Dispositional Characterization of Its N-Carbamoyl Glucuronide Metabolite

Christopher L. Shaffer, Tim F. Ryder, Karthik Venkatakrishnan, Ilana K. Henne and Thomas N. O'Connell
Drug Metabolism and Disposition July 2009, 37 (7) 1480-1489; DOI: https://doi.org/10.1124/dmd.109.027037
Christopher L. Shaffer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim F. Ryder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karthik Venkatakrishnan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilana K. Henne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas N. O'Connell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 37 no. 7 1480-1489
DOI 
https://doi.org/10.1124/dmd.109.027037
PubMed 
19339375

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Accepted March 27, 2009
  • Received February 2, 2009
  • Published online June 18, 2009.

Article Versions

  • Earlier version (April 1, 2009 - 07:58).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Christopher L. Shaffer,
  2. Tim F. Ryder,
  3. Karthik Venkatakrishnan1,
  4. Ilana K. Henne2 and
  5. Thomas N. O'Connell
  1. Departments of Pharmacokinetics, Pharmacodynamics, and Metabolism (C.L.S., T.F.R., K.V., I.K.H.) and Exploratory Medicinal Sciences (T.N.O.), Pfizer Global Research and Development, Groton/New London Laboratories, Pfizer Inc., Groton, Connecticut
  1. Address correspondence to:
    Dr. Christopher L. Shaffer, Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, Groton/New London Laboratories, Pfizer Inc., Eastern Point Road, MS 8220-4186, Groton, CT 06340. E-mail: christopher.l.shaffer{at}pfizer.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201701313
Sep 201721912
Oct 201702721
Nov 201722012
Dec 201701711
Jan 201822011
Feb 201811815
Mar 20180195
Apr 20181233
May 20180185
Jun 20180183
Jul 20180124
Aug 20180138
Sep 2018082
Oct 20180192
Nov 20180108
Dec 2018722
Jan 20191121
Feb 2019500
Mar 20191102
Apr 20191504
May 20191901
Jun 2019302
Jul 2019707
Aug 2019701
Oct 20191200
Nov 20191201
Dec 20191720
Jan 20201325
Feb 20203002
Mar 2020704
May 20201400
Jun 2020511
Jul 2020500
Aug 2020401
Sep 2020702
Oct 20201012
Nov 20201631
Dec 2020900
Jan 20211754
Feb 20211040
Mar 20212222
Apr 2021910
May 2021820
Jun 20211520
Jul 20212413
Aug 20211521
Sep 20211020
Oct 20211110
Nov 20211714
Dec 20212244
Jan 20221321
Feb 2022430
Mar 2022310
Apr 20221030
May 20221623
Jun 20222134
Jul 202218113
Aug 20221411
Sep 2022811
Oct 2022914
Nov 20221445
Dec 20221514
Jan 20231753
Feb 2023914
Mar 2023711

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (7)
Drug Metabolism and Disposition
Vol. 37, Issue 7
1 Jul 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Biotransformation of an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist in Sprague-Dawley Rats and the Dispositional Characterization of Its N-Carbamoyl Glucuronide Metabolite
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Biotransformation of an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist in Sprague-Dawley Rats and the Dispositional Characterization of Its N-Carbamoyl Glucuronide Metabolite

Christopher L. Shaffer, Tim F. Ryder, Karthik Venkatakrishnan, Ilana K. Henne and Thomas N. O'Connell
Drug Metabolism and Disposition July 1, 2009, 37 (7) 1480-1489; DOI: https://doi.org/10.1124/dmd.109.027037

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Biotransformation of an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist in Sprague-Dawley Rats and the Dispositional Characterization of Its N-Carbamoyl Glucuronide Metabolite

Christopher L. Shaffer, Tim F. Ryder, Karthik Venkatakrishnan, Ilana K. Henne and Thomas N. O'Connell
Drug Metabolism and Disposition July 1, 2009, 37 (7) 1480-1489; DOI: https://doi.org/10.1124/dmd.109.027037
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • AKRs and GUSs in Testosterone Disposition
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics